- Allera collaborating with H. Lee Moffitt Cancer Center researchers More
- Moffitt Physician-Scientist demonstrates Proligna enhances immune response MORE
- National Cancer Institute evaluates Allera data for "Best Case Series" MORE
- Allera to complete Osteoarthritis clinical study enrollment MORE
- Allera launches retail sales of ImmunExtra®, proprietary product for Immune cell development MORE
Allera is a research and development company dedicated to providing innovative, natural products that enhance the immune system.
Allera’s first products are based on Proligna, an all natural, preservative-free, patented, botanical compound first studied in Japan and developed by scientists at the Tampa Bay Research Institute in Florida.
Laboratory studies have shown that Proligna possesses unique antibacterial, anti-tumor, and anti-inflammatory activities. Research continues to determine its potential.